This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
ACM Research, Inc. Class A
ArcelorMittal SA ADR
Harmony Biosciences Holdings, Inc.
Nuvectis Pharma, Inc.
Evommune, Inc.
ACM Research, Inc. Class A ACMR | 0.00 | |
ArcelorMittal SA ADR MT | 0.00 | |
Harmony Biosciences Holdings, Inc. HRMY | 0.00 | |
Nuvectis Pharma, Inc. NVCT | 0.00 | |
Evommune, Inc. EVMN | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Needham analyst Serge Belanger initiated coverage on Evommune Inc (NYSE:EVMN) with a Buy rating and announced a price target of $28. Evommune closed at $13.79 on Tuesday. See how other analysts view this stock.
- Daiwa Capital analyst Bintuo Ni initiated coverage on ACM Research Inc (NASDAQ:ACMR) with a Buy rating and announced a price target of $136. ACM Research shares closed at $79.77 on Tuesday. See how other analysts view this stock.
- Wolfe Research analyst Rudy Li initiated coverage on Harmony Biosciences Holdings Inc (NASDAQ:HRMY) with an Outperform rating and announced a price target of $60. Harmony Biosciences closed at $38.95 on Tuesday. See how other analysts view this stock.
- RBC Capital analyst Matthew Hedberg initiated coverage on Atlassian Corp (NASDAQ:TEAM) with an Outperform rating and announced a price target of $215. Atlassian shares closed at $166.49 on Tuesday. See how other analysts view this stock.
- RBC Capital analyst Matthew Hedberg initiated coverage on JFrog Ltd (NASDAQ:FROG) with an Outperform rating and announced a price target of $118. JFrog closed at $89.48 on Tuesday. See how other analysts view this stock.
Considering buying ACMR stock? Here’s what analysts think:
Photo via Shutterstock